Last 12 months
Inside the activity.
0 purchase rows · 56 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 8 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2021 Filed Jan 8, 2021 02:17 UTC |
Wagner John BrandonCFO and Treasurer
|
Exercise / conversionClass A Common Stock | 2,000 | $6.88 | $13,760.00 |
DisclosureSEC source: 0000899243-21-001034 · doc4.xml · nonDerivative · entry 4 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 02:17 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 1,800 | $38.45 | $69,210.00 |
DisclosureSEC source: 0000899243-21-001034 · doc4.xml · nonDerivative · entry 3 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,770 F1 · shares: Sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020, as amended on November 10, 2020. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 02:17 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 2,000 | $36.60 | $73,200.00 |
DisclosureSEC source: 0000899243-21-001034 · doc4.xml · nonDerivative · entry 2 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,570 F1 · shares: Sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020, as amended on November 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.45 to $37.26, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| January 05, 2021 Filed Jan 8, 2021 02:17 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 7,125 | $36.91 | $262,983.75 |
DisclosureSEC source: 0000899243-21-001034 · doc4.xml · nonDerivative · entry 1 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,570 F1 · shares: Sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020, as amended on November 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.46 to $37.14, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 23:36 UTC |
Suzuki EugeneChief Information Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0000899243-21-000483 · doc4.xml · derivative · entry 4 Suzuki Eugene · CIK 0001744443 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,000 shares Expires 2022-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on April 4, 2012 and was exercisable for up to an aggregate total of 278,040 shares of Class B Common Stock, which shares fully vested as of January 31, 2016. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 23:36 UTC |
Suzuki EugeneChief Information Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0000899243-21-000483 · doc4.xml · derivative · entry 3 Suzuki Eugene · CIK 0001744443 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Class A Common Stock · 4,000 shares Expires 2022-04-04 F1 · kind: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on April 4, 2012 and was exercisable for up to an aggregate total of 278,040 shares of Class B Common Stock, which shares fully vested as of January 31, 2016. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on April 4, 2012 and was exercisable for up to an aggregate total of 278,040 shares of Class B Common Stock, which shares fully vested as of January 31, 2016. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 23:36 UTC |
Suzuki EugeneChief Information Officer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0000899243-21-000483 · doc4.xml · derivative · entry 2 Suzuki Eugene · CIK 0001744443 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,856 Underlying: Class B Common Stock · 4,000 shares Expires 2022-04-04 F1 · kind: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on April 4, 2012 and was exercisable for up to an aggregate total of 278,040 shares of Class B Common Stock, which shares fully vested as of January 31, 2016. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on April 4, 2012 and was exercisable for up to an aggregate total of 278,040 shares of Class B Common Stock, which shares fully vested as of January 31, 2016. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 23:36 UTC |
Suzuki EugeneChief Information Officer
|
Exercise / conversionClass A Common Stock | 4,000 | $0.42 | $1,680.00 |
DisclosureSEC source: 0000899243-21-000483 · doc4.xml · nonDerivative · entry 1 Suzuki Eugene · CIK 0001744443 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2020 Filed Dec 29, 2020 23:13 UTC |
Mendal JaymeDirector · CEO and President
|
SaleClass A Common Stock | 94 | $37.91 | $3,563.54 |
DisclosureSEC source: 0000899243-20-035435 · doc4.xml · nonDerivative · entry 3 Mendal Jayme · CIK 0001744403 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,635 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020, as amended on May 20, 2020 and August 17, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.07, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| December 29, 2020 Filed Dec 29, 2020 23:13 UTC |
Mendal JaymeDirector · CEO and President
|
SaleClass A Common Stock | 756 | $37.15 | $28,085.40 |
DisclosureSEC source: 0000899243-20-035435 · doc4.xml · nonDerivative · entry 2 Mendal Jayme · CIK 0001744403 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,729 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020, as amended on May 20, 2020 and August 17, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.61 to $37.57, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| December 29, 2020 Filed Jan 5, 2021 01:35 UTC |
Revesz Tomas JrChief Technology Officer
|
SaleClass A Common Stock | 10,324 | $37.25 | $384,569.00 |
DisclosureSEC source: 0000899243-21-000228 · doc4.xml · nonDerivative · entry 1 Revesz Tomas Jr · CIK 0001744802 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,894 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2019 and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 28, 2020. The sales do not represent a discretionary trade by the reporting person. Read SEC document |
| December 23, 2020 Filed Dec 29, 2020 23:13 UTC |
Mendal JaymeDirector · CEO and President
|
SaleClass A Common Stock | 1,946 | $40.47 | $78,754.62 |
DisclosureSEC source: 0000899243-20-035435 · doc4.xml · nonDerivative · entry 1 Mendal Jayme · CIK 0001744403 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,485 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020, as amended on May 20, 2020 and August 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.09 to $41.07, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 11:10 UTC |
Wagner John BrandonCFO and Treasurer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,559 | $0.00 Strike: $6.88 | $0.00 |
DisclosureSEC source: 0000899243-20-035113 · doc4.xml · derivative · entry 6 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,559 shares Expires 2026-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 20,000 shares of Class B Common Stock, which shares fully vested as of January 11, 2020. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 11:10 UTC |
Wagner John BrandonCFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,559 | $0.00 Strike: $6.88 | $0.00 |
DisclosureSEC source: 0000899243-20-035113 · doc4.xml · derivative · entry 5 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,559 Underlying: Class A Common Stock · 3,559 shares Expires 2026-01-10 F2 · kind: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 20,000 shares of Class B Common Stock, which shares fully vested as of January 11, 2020. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 20,000 shares of Class B Common Stock, which shares fully vested as of January 11, 2020. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 11:10 UTC |
Wagner John BrandonCFO and Treasurer
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 3,559 | $0.00 Strike: $6.88 | $0.00 |
DisclosureSEC source: 0000899243-20-035113 · doc4.xml · derivative · entry 4 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,441 Underlying: Class B Common Stock · 3,559 shares Expires 2026-01-10 F2 · kind: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 20,000 shares of Class B Common Stock, which shares fully vested as of January 11, 2020. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 20,000 shares of Class B Common Stock, which shares fully vested as of January 11, 2020. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 11:10 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 1,559 | $39.45 | $61,502.55 |
DisclosureSEC source: 0000899243-20-035113 · doc4.xml · nonDerivative · entry 3 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,695 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020, as amended on November 10, 2020. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 11:10 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 2,000 | $38.45 | $76,900.00 |
DisclosureSEC source: 0000899243-20-035113 · doc4.xml · nonDerivative · entry 2 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,254 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020, as amended on November 10, 2020. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 11:10 UTC |
Wagner John BrandonCFO and Treasurer
|
Exercise / conversionClass A Common Stock | 3,559 | $6.88 | $24,485.92 |
DisclosureSEC source: 0000899243-20-035113 · doc4.xml · nonDerivative · entry 1 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2020 Filed Jan 9, 2023 21:10 UTC Amendment |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 1,000 | $38.45 | $38,450.00 |
DisclosureSEC source: 0000899243-23-001294 · doc4a.xml · nonDerivative · entry 1 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,892 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2020, as amended on November 10, 2020. F2 · shares: The Reporting Person inadvertently failed to report the sale of these shares of Class A Common Stock on the Form 4 filed on December 28, 2020, and therefore, the total amount of securities beneficially owned by the Reporting Person and reported in column 5 of Table I was overstated by the amount of these shares in each of the Forms 4 filed after December 28, 2020 and before January 9, 2023. F3 · balance_after: The amount of securities beneficially owned that is reported on this line is as of December 22, 2020. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:18 UTC |
Neble George RDirector
|
SaleClass A Common Stock | 500 | $36.30 | $18,150.00 |
DisclosureSEC source: 0000899243-20-034305 · doc4.xml · nonDerivative · entry 1 Neble George R · CIK 0001744442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,355 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2020. Read SEC document |
| December 14, 2020 Filed Dec 15, 2020 00:19 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 2,799 | $36.45 | $102,023.55 |
DisclosureSEC source: 0000899243-20-033785 · doc4.xml · nonDerivative · entry 4 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,695 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020, as amended on November 10, 2020. Read SEC document |
| December 14, 2020 Filed Dec 15, 2020 00:19 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 2,799 | $34.45 | $96,425.55 |
DisclosureSEC source: 0000899243-20-033785 · doc4.xml · nonDerivative · entry 3 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,494 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020, as amended on November 10, 2020. Read SEC document |
| December 10, 2020 Filed Dec 15, 2020 00:19 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 100 | $32.84 | $3,284.00 |
DisclosureSEC source: 0000899243-20-033785 · doc4.xml · nonDerivative · entry 2 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,293 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020, as amended on November 10, 2020. Read SEC document |
| December 10, 2020 Filed Dec 15, 2020 00:19 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 3,025 | $32.40 | $98,010.00 |
DisclosureSEC source: 0000899243-20-033785 · doc4.xml · nonDerivative · entry 1 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,393 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.69 to $32.67, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020, as amended on November 10, 2020. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:53 UTC |
Mendal JaymeCEO & President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $6.96 | $0.00 |
DisclosureSEC source: 0000899243-20-032763 · doc4.xml · derivative · entry 2 Mendal Jayme · CIK 0001744403 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,880 Underlying: Class A Common Stock · 20,000 shares Expires 2027-10-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase 266,880 shares, was granted on October 18, 2017. The shares underlying the option vested on various dates commencing on September 30, 2018. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:53 UTC |
Mendal JaymeCEO & President
|
Exercise / conversionClass A Common Stock | 20,000 | $6.96 | $139,200.00 |
DisclosureSEC source: 0000899243-20-032763 · doc4.xml · nonDerivative · entry 1 Mendal Jayme · CIK 0001744403 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 01:31 UTC |
Mendal JaymeCEO and President
|
SaleClass A Common Stock | 1,110 | $37.80 | $41,958.00 |
DisclosureSEC source: 0000899243-20-032406 · doc4.xml · nonDerivative · entry 5 Mendal Jayme · CIK 0001744403 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,431 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020, as amended on May 20, 2020 and August 17, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.69 to $38.00, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 01:31 UTC |
Mendal JaymeCEO and President
|
SaleClass A Common Stock | 18,890 | $37.11 | $701,007.90 |
DisclosureSEC source: 0000899243-20-032406 · doc4.xml · nonDerivative · entry 4 Mendal Jayme · CIK 0001744403 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,541 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020, as amended on May 20, 2020 and August 17, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.69 to $37.67, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 27, 2020 Filed Dec 2, 2020 01:31 UTC |
Mendal JaymeCEO and President
|
SaleClass A Common Stock | 271 | $43.16 | $11,696.36 |
DisclosureSEC source: 0000899243-20-032406 · doc4.xml · nonDerivative · entry 3 Mendal Jayme · CIK 0001744403 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,431 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020, as amended on May 20, 2020 and August 17, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.06 to $43.20, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 27, 2020 Filed Dec 2, 2020 01:31 UTC |
Mendal JaymeCEO and President
|
SaleClass A Common Stock | 928 | $42.44 | $39,384.32 |
DisclosureSEC source: 0000899243-20-032406 · doc4.xml · nonDerivative · entry 2 Mendal Jayme · CIK 0001744403 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,702 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020, as amended on May 20, 2020 and August 17, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.06 to $43.04, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 27, 2020 Filed Dec 2, 2020 01:31 UTC |
Mendal JaymeCEO and President
|
SaleClass A Common Stock | 2,051 | $41.55 | $85,219.05 |
DisclosureSEC source: 0000899243-20-032406 · doc4.xml · nonDerivative · entry 1 Mendal Jayme · CIK 0001744403 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,630 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020, as amended on May 20, 2020 and August 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.05 to $42.04, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 22:16 UTC |
Neumeier ElyseChief People Officer
|
SaleClass A Common Stock | 109 | $38.66 | $4,213.94 |
DisclosureSEC source: 0000899243-20-031670 · doc4.xml · nonDerivative · entry 1 Neumeier Elyse · CIK 0001789475 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,852 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2019, and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 15, 2020. The sales do not represent a discretionary trade by the reporting person. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 02:35 UTC |
Auguste DarrylDirector · See Remarks
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,553 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0000899243-20-031360 · doc4.xml · derivative · entry 9 Auguste Darryl · CIK 0001744445 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 11,553 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on February 26, 2015 and was exercisable for up to an aggregate total of 56,000 shares of Class B Common Stock, which shares fully vested as of February 26, 2019. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 02:35 UTC |
Auguste DarrylDirector · See Remarks
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,553 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0000899243-20-031360 · doc4.xml · derivative · entry 8 Auguste Darryl · CIK 0001744445 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,553 Underlying: Class A Common Stock · 11,553 shares Expires 2025-02-25 F3 · kind: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on February 26, 2015 and was exercisable for up to an aggregate total of 56,000 shares of Class B Common Stock, which shares fully vested as of February 26, 2019. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. F3 · derivative.exercise_date: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on February 26, 2015 and was exercisable for up to an aggregate total of 56,000 shares of Class B Common Stock, which shares fully vested as of February 26, 2019. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 02:35 UTC |
Auguste DarrylDirector · See Remarks
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 11,553 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0000899243-20-031360 · doc4.xml · derivative · entry 7 Auguste Darryl · CIK 0001744445 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,447 Underlying: Class B Common Stock · 11,553 shares Expires 2025-02-25 F3 · kind: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on February 26, 2015 and was exercisable for up to an aggregate total of 56,000 shares of Class B Common Stock, which shares fully vested as of February 26, 2019. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. F3 · derivative.exercise_date: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on February 26, 2015 and was exercisable for up to an aggregate total of 56,000 shares of Class B Common Stock, which shares fully vested as of February 26, 2019. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 02:35 UTC |
Auguste DarrylDirector · See Remarks
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.89 | $0.00 |
DisclosureSEC source: 0000899243-20-031360 · doc4.xml · derivative · entry 6 Auguste Darryl · CIK 0001744445 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,000 shares Expires 2026-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 80,000 shares of Class B Common Stock, which shares vest over six years in seventy-two equal monthly installments with the first installment vested on February 28, 2017. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 02:35 UTC |
Auguste DarrylDirector · See Remarks
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.89 | $0.00 |
DisclosureSEC source: 0000899243-20-031360 · doc4.xml · derivative · entry 5 Auguste Darryl · CIK 0001744445 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2026-01-10 F2 · kind: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 80,000 shares of Class B Common Stock, which shares vest over six years in seventy-two equal monthly installments with the first installment vested on February 28, 2017. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. F2 · derivative.exercise_date: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 80,000 shares of Class B Common Stock, which shares vest over six years in seventy-two equal monthly installments with the first installment vested on February 28, 2017. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 02:35 UTC |
Auguste DarrylDirector · See Remarks
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.89 | $0.00 |
DisclosureSEC source: 0000899243-20-031360 · doc4.xml · derivative · entry 4 Auguste Darryl · CIK 0001744445 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Class B Common Stock · 10,000 shares Expires 2026-01-10 F2 · kind: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 80,000 shares of Class B Common Stock, which shares vest over six years in seventy-two equal monthly installments with the first installment vested on February 28, 2017. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. F2 · derivative.exercise_date: The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 80,000 shares of Class B Common Stock, which shares vest over six years in seventy-two equal monthly installments with the first installment vested on February 28, 2017. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 02:35 UTC |
Auguste DarrylDirector · See Remarks
|
SaleClass A Common Stock | 24,152 | $40.56 | $979,605.12 |
DisclosureSEC source: 0000899243-20-031360 · doc4.xml · nonDerivative · entry 3 Auguste Darryl · CIK 0001744445 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,998 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.23 to $41.03, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 02:35 UTC |
Auguste DarrylDirector · See Remarks
|
Exercise / conversionClass A Common Stock | 11,553 | $4.82 | $55,685.46 |
DisclosureSEC source: 0000899243-20-031360 · doc4.xml · nonDerivative · entry 2 Auguste Darryl · CIK 0001744445 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 02:35 UTC |
Auguste DarrylDirector · See Remarks
|
Exercise / conversionClass A Common Stock | 10,000 | $6.89 | $68,900.00 |
DisclosureSEC source: 0000899243-20-031360 · doc4.xml · nonDerivative · entry 1 Auguste Darryl · CIK 0001744445 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 00:17 UTC |
DENINGER PAUL FDirector
|
PurchaseClass A Common Stock | 400 | $39.67 | $15,868.00 |
DisclosureSEC source: 0000899243-20-030679 · doc4.xml · nonDerivative · entry 3 DENINGER PAUL F · CIK 0001190861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,124 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.35 to $39.99, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 09, 2020 Filed Nov 24, 2020 01:00 UTC |
Graham NicholasChief Revenue Officer
|
SaleClass A Common Stock | 1,310 | $40.71 | $53,330.10 |
DisclosureSEC source: 0000899243-20-031977 · doc4.xml · nonDerivative · entry 3 Graham Nicholas · CIK 0001833226 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,261 Read SEC document |
| November 09, 2020 Filed Nov 24, 2020 01:00 UTC |
Graham NicholasChief Revenue Officer
|
SaleClass A Common Stock | 1,787 | $39.35 | $70,318.45 |
DisclosureSEC source: 0000899243-20-031977 · doc4.xml · nonDerivative · entry 2 Graham Nicholas · CIK 0001833226 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,571 Read SEC document |
| November 09, 2020 Filed Nov 24, 2020 01:00 UTC |
Graham NicholasChief Revenue Officer
|
SaleClass A Common Stock | 1,202 | $39.35 | $47,298.70 |
DisclosureSEC source: 0000899243-20-031977 · doc4.xml · nonDerivative · entry 1 Graham Nicholas · CIK 0001833226 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,358 F1 · shares: The sales reported in this Form 4 represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2020. The sales do not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.35 to $40.00, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 00:17 UTC |
Shields John L.Director
|
SaleClass A Common Stock | 6,210 | $40.00 | $248,400.00 |
DisclosureSEC source: 0000899243-20-030678 · doc4.xml · nonDerivative · entry 2 Shields John L. · CIK 0001744788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,955 Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 00:17 UTC |
DENINGER PAUL FDirector
|
PurchaseClass A Common Stock | 350 | $39.01 | $13,653.50 |
DisclosureSEC source: 0000899243-20-030679 · doc4.xml · nonDerivative · entry 2 DENINGER PAUL F · CIK 0001190861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,724 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.85 to $39.04, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 00:16 UTC |
Mason David WGeneral Counsel and Secretary
|
SaleClass A Common Stock | 412 | $39.77 | $16,385.24 |
DisclosureSEC source: 0000899243-20-030677 · doc4.xml · nonDerivative · entry 2 Mason David W · CIK 0001744907 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,301 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $39.81, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 00:16 UTC |
Mason David WGeneral Counsel and Secretary
|
SaleClass A Common Stock | 6,713 | $39.37 | $264,290.81 |
DisclosureSEC source: 0000899243-20-030677 · doc4.xml · nonDerivative · entry 1 Mason David W · CIK 0001744907 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,713 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.73, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 00:13 UTC |
Wagner John BrandonCFO and Treasurer
|
SaleClass A Common Stock | 7,087 | $39.50 | $279,936.50 |
DisclosureSEC source: 0000899243-20-030675 · doc4.xml · nonDerivative · entry 2 Wagner John Brandon · CIK 0001744433 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.